Sergio Lavandero had received the Ph.D. degree and is currently a Professor at the Faculty of Chemical and Pharmaceutical Sciences and Faculty of Medicine, Director at the Excellence Center for Chronic Diseases (ACCDiS), and Vice Chancellor for Research of the University of Chile, Santiago, Chile. He is a Visiting Professor at the Department of Internal Medicine (Cardiology Division), University of Texas Southwestern Medical Center, Dallas, TX, USA, between 2010 and 2015. Lavandero has made important contributions to cardiovascular research through his groundbreaking work in the fields of cell biology and biochemistry. He has explored the signaling mechanisms of cell death; survival and hypertrophy regulation in cardiac cells; the signaling pathways that explain metabolism; mitochondrial dynamics; and autophagy in cardiac pathologies such as heart failure, ischemic disease, hypertension, and atrial fibrillation. He currently serves in different editorial boards. These include American Journal of Physiology (Section Endocrinology and Metabolism), Biological Research, and ISRN Cardiology. He has more than 164 scientific publications and 3 patents. He is a Member of the Board of International Cell Death Society, Member of the American Society for Biochemistry and Molecular Biology, and President of the Chilean Society for Biochemistry and Molecular Biology. He is an International Member of the European Research Institute for Integrated Cellular Pathology. He was acting as the President and Representative for the area of biological sciences at the Senior Scientific Council FONDECYT/CONICYT in Chile.
Biography Updated on 8 February 2014